Recombinant Human IL4R Protein (Gly24-His232), C-6×His-tagged
Product Description
Cat
IMP-10468
Official Symbol
IL4R
Product Overview
Recombinant human IL-4R alpha protein (Gly24-His232) with C-terminal 6×His tag was expressed in Chinese Hamster Ovary cell line.
Description
This gene encodes the alpha chain of the interleukin-4 receptor, a type I transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate IgE production. The encoded protein also can bind interleukin 4 to promote differentiation of Th2 cells. A soluble form of the encoded protein can be produced by proteolysis of the membrane-bound protein, and this soluble form can inhibit IL4-mediated cell proliferation and IL5 upregulation by T-cells. Allelic variations in this gene have been associated with atopy, a condition that can manifest itself as allergic rhinitis, sinusitus, asthma, or eczema. Polymorphisms in this gene are also associated with resistance to human immunodeficiency virus type-1 infection. Alternate splicing results in multiple transcript variants.
Expression System
CHO
Species
Human
Tag
C-6×His
Predicted N Terminal
Gly24
Form
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Molecular Mass
Predicted Molecular Mass: 25 kDa
SDS-PAGE: 49-58 kDa, under reducing conditions.
Protein length
Gly24-His232
Bio-activity
Measured by its ability to inhibit IL-4-dependent proliferation of TF-1 human erythroleukemic cells. Approximately 3.00-20.0 ng/mL of IL-4 R alpha will inhibit 50% of the biological response due to 0.2 ng/mL of recombinant human IL-4.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 500 μg/mL in PBS.
SDS-PAGE
SDS-PAGE

Bioactivity-ELISA 1
Bioactivity

Measured by its ability to inhibit IL-4-dependent proliferation of TF-1 human erythroleukemic cells. Approximately 3.00-20.0 ng/mL of IL-4 R alpha will inhibit 50% of the biological response due to 0.2 ng/mL of recombinant human IL-4.

Data Sheet MSDS
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry
Contact Info